Till Seiler

V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia

Alexander Kröber, Till Seiler, Axel Benner et al. · Blood · 2002 · 781 citations

Medicine, Hematology, Oncology +12

Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation

Rosa Catera, Gregg J. Silverman, Katerina Hatzi et al. · Molecular Medicine · 2008 · 210 citations · Full text

Life Sciences, Cell Biology, Immunology +16

Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and <i>V3-21</i> Usage Characterize Discordance of ZAP-70 and <i>VH</i> Mutation Status in Chronic Lymphocytic Leukemia

Alexander Kröber, Johannes Bloehdorn, Sebastian Häfner et al. · Journal of Clinical Oncology · 2006 · 193 citations · Full text

Medicine, Hematology, Oncology +15

Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial

Paula Cramer, Julia von Tresckow, Jasmin Bahlo et al. · The Lancet Oncology · 2018 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +11

Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque–triggered thrombus formation in humans

Kristina Busygina, Janina Jamasbi, Till Seiler et al. · Blood · 2018 · 90 citations · Full text

Medicine, Cardiology, Pharmacology +16